February 15, 2023
February 15, 2023
Categories

ASCO Living Guideline says ‘no’ to anti-VEGF-chemo combo in non-small cell lung cancer without driver alterations, based on data from the E5508 trial

Do you like it?
Read more
February 10, 2023
February 10, 2023
Categories

ECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)

Do you like it?
Read more
February 9, 2023
February 9, 2023
Categories

The application period is now open for Spring Meeting Attendance Awards for minority trainees

Do you like it?
Read more
February 6, 2023
February 6, 2023
Categories

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

Do you like it?
Read more
February 1, 2023
February 1, 2023
Categories

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

Do you like it?
Read more
January 30, 2023
January 30, 2023
Categories

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

Do you like it?
Read more
January 24, 2023
January 24, 2023
Categories

Blinatumomab significantly improves overall survival in newly diagnosed B-ALL patients who are MRD-negative after initial treatment (study E1910)

Do you like it?
Read more
December 19, 2022
December 19, 2022
Categories

Blinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL

Do you like it?
Read more
December 15, 2022
December 15, 2022
Categories

Study E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group